Example: Heart Attack

Search clinical trials for: Imipenem

Total 82 results

NCT03776305

Unknown status

Imipenem in Critically Ill Patients

Conditions: Critically Ill Patients With ECMO
NCT02897206

Completed

Imipenem Prophylaxis in Patients With Acute Pancreatitis

Conditions: Acute Pancreatitis
NCT03308214

Completed

The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock Patients

Conditions: Septic Shock
NCT04147221

Recruiting

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

Conditions: Sepsis
NCT00950222

Completed

Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic

Conditions: Ventilator Associated Pneumonia
NCT02616354

Unknown status

Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin

Conditions: Sepsis
NCT04493151

Not yet recruiting

Imipenem/Cilastatin/Relebactam PK in ECMO

Conditions: Sepsis
NCT01489124

Completed

The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia

Conditions: Ventilator-Associated Pneumonia
NCT03293485

Completed

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Conditions: Complicated Intra-abdominal Infection; Complicated Urinary Tract Infection
NCT02213783

Completed

Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia

Conditions: Patients With Febrile Neutropenia
NCT03733340

Unknown status

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

Conditions: Antibacterial Prophylaxis; Hematological Malignancies; Allogenetic Hematopoietic Stem Cell Transplantation; Imipenem
NCT01379157

Completed

Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia

Conditions: Ventilator Associated Pneumonia
NCT03858387

Recruiting

PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients

Conditions: Critical Illness; Bacterial Infections
NCT01852630

Completed

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Conditions: Spontaneous Bacterial Peritonitis
NCT02321800

Completed

A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Conditions: Urinary Tract Infections
NCT03177720

Recruiting

Evaluation of Innovative Tools in Development of Antibiotics

Conditions: Pneumonia
NCT00589693

Terminated

To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia

Conditions: Ventilator-Associated Pneumonia
NCT02474706

Terminated

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

Conditions: Urinary Tract Infections
NCT02149329

Completed

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO

Conditions: Febrile Neutropenia; Hematological Malignancy
NCT02452047

Completed

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)

Conditions: Bacterial Infections
NCT00871104

Completed

Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis

Conditions: Infective Endocarditis
NCT01505634

Completed

Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)

Conditions: Urinary Tract Infections; Pyelonephritis
NCT04208763

Recruiting

A Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF for the Management of Spontaneous Bacterial Peritonitis Presenting With Septic Shock.

Conditions: Spontaneous Bacterial Peritonitis
NCT01297842

Unknown status

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Conditions: Drug Safety
NCT04196608

Recruiting

In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients

Conditions: Ceftolozane/Tazobactam; Imipenem/Relebactam; Hematology and Oncology